Imago BioSciences (IMGO) Files $400M Mixed Shelf streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
- Positive Data from the Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia Presented at European Hematology Association Meeting 2022 - - Positive Data from the Ongoing Phase 2 Study. | August 12, 2022
Fred Hutchinson Cancer Center lung cancer scientists open a human trial after preclinical work shows that making small cell lung cancer more visible to immune cells can make the tumors more responsive to immunotherapy.
Imago BioSciences to Participate in the 2022 Wedbush PacGrow Healthcare Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.